Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Inflammatory demyelinating diseases CNS Core Data Set

Inflammatory demyelinating diseases CNS Core Data Set

Diagnosis Demyelinating disease of central nervous system
Description

Diagnosis Demyelinating disease of central nervous system

Alias
UMLS CUI-1
C0011900
UMLS CUI-2
C0011302
Current Diagnosis
Description

Current diagnosis

Data type

text

Alias
UMLS CUI [1]
C0011900
Other CNS demyelinating disorder
Description

Other CNS demyelinating disorder

Data type

text

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0205394
Date of onset
Description

Date of Onset

Data type

date

Alias
UMLS CUI [1]
C0574845
Date of diagnosis
Description

Date of Diagnosis

Data type

date

Alias
UMLS CUI [1]
C2316983
Current Flare
Description

Current Flare

Current flare?
Description

Current flare

Data type

boolean

Alias
UMLS CUI [1,1]
C1517205
UMLS CUI [1,2]
C0521116
Current Therapy Flare
Description

Therapy Flare

Data type

text

Alias
UMLS CUI [1,1]
C1517205
UMLS CUI [1,2]
C2827774
Other therapy for current flare
Description

Other Therapy Flare

Data type

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C2827774
UMLS CUI [1,3]
C1517205
Start date of current flare therapy
Description

Start Date Current Flare Therapy

Data type

date

Alias
UMLS CUI [1]
C3173309
End date of current flare therapy
Description

End Date Current Flare Therapy

Data type

date

Alias
UMLS CUI [1]
C1531784
Multiple Sclerosis
Description

Multiple Sclerosis

Alias
UMLS CUI-1
C0026769
Clinical course of multiple sclerosis
Description

Clinical Course MS

Data type

integer

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0026769
Other clinical course
Description

Other clinical course MS

Data type

text

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0205394
Neuromyelitis optica
Description

Neuromyelitis optica

Alias
UMLS CUI-1
C0027873
Clinical course of NMO Spectrum Disorder
Description

Clinical course NMO

Data type

text

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0027873
Other clinical course
Description

Other clinical course NMO

Data type

text

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0205394
Aquaporin-4 antibody
Description

Aquaporin-4 antibody

Data type

text

Alias
UMLS CUI [1]
C2919772
anti-MOG (Myelin oligodendrocyte glycoprotein) antibodies
Description

anti-MOG antibody

Data type

text

Alias
UMLS CUI [1,1]
C0003241
UMLS CUI [1,2]
C3266851
Acute Disseminated Encephalomyelitis (ADEM)
Description

Acute Disseminated Encephalomyelitis (ADEM)

Alias
UMLS CUI-1
C0014059
Clinical course of ADEM
Description

Clinical course ADEM

Data type

text

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0014059
Other clinical course
Description

Other clinical course ADEM

Data type

text

Alias
UMLS CUI [1,1]
C0449259
UMLS CUI [1,2]
C0205394
EDSS
Description

EDSS

Today's EDSS
Description

Current EDSS

Data type

text

Alias
UMLS CUI [1]
C3830336
KFSS Pyramidal Functions
Description

KFSS Pyramidal

Data type

text

Alias
UMLS CUI [1]
C3829393
KFSS Sensory Functions
Description

KFSS Sensory

Data type

text

Alias
UMLS CUI [1]
C3829391
KFSS Cerebral
Description

KFSS Cerebral

Data type

text

Alias
UMLS CUI [1]
C3829397
KFSS Cerebellar Functions
Description

KFSS Cerebellar

Data type

text

Alias
UMLS CUI [1]
C3829398
KFSS Bowel and Bladder Functions
Description

KFSS Bowel and Bladder

Data type

text

Alias
UMLS CUI [1]
C3829400
KFSS Brain Stem Functions
Description

KFSS Brain Stem

Data type

text

Alias
UMLS CUI [1]
C3829399
KFSS Visual (or Optic) Functions
Description

KFSS Visual

Data type

text

Alias
UMLS CUI [1]
C3827261
FSS Ambulation Score
Description

Source: Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA,Weiner HL. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983 Jan 27;308(4):173-80.

Data type

text

Alias
UMLS CUI [1]
C115790
Current MS therapy
Description

Current MS therapy

Active ingredient in current therapy
Description

Current Agent

Data type

text

Alias
UMLS CUI [1,1]
C2827774
UMLS CUI [1,2]
C0026769
Other active ingredient in current therapy
Description

Other Current Agent

Data type

text

Alias
UMLS CUI [1,1]
C2827774
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0026769
Start date of current therapy
Description

Start Date Current Therapy

Data type

date

Alias
UMLS CUI [1,1]
C3173309
UMLS CUI [1,2]
C2827774
UMLS CUI [1,3]
C0026769
Previous disease-modifying MS-Medication
Description

Previous disease-modifying MS-Medication

Was a disease-modifying MS therapy previously conducted?
Description

Previous Therapy MS

Data type

boolean

Alias
UMLS CUI [1,1]
C2114510
UMLS CUI [1,2]
C0026769
Active ingredient in previous therapy
Description

Previous Agent

Data type

integer

Alias
UMLS CUI [1,1]
C2114510
UMLS CUI [1,2]
C0026769
Other active ingredient of previous therapy
Description

Other Previous Agent

Data type

text

Alias
UMLS CUI [1,1]
C2114510
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0026769
Start date of previous therapy
Description

Start Date Previous Therapy

Data type

date

Alias
UMLS CUI [1,1]
C3173309
UMLS CUI [1,2]
C2114510
UMLS CUI [1,3]
C0026769
End date of previous therapy
Description

End Date Previous Therapy

Data type

date

Alias
UMLS CUI [1,1]
C1531784
UMLS CUI [1,2]
C2114510
UMLS CUI [1,3]
C0026769
Main reason for stopping the previous therapy
Description

Reason Stop Therapy

Data type

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0566251
UMLS CUI [1,3]
C0026769
If other reasion for stopping previous therapy, please indicate the reason
Description

Other Reason Stop Therapy

Data type

text

Alias
UMLS CUI [1,1]
C3840932
UMLS CUI [1,2]
C0850893
UMLS CUI [1,3]
C0026769
MRI Multiple Sclerosis
Description

MRI Multiple Sclerosis

MRI available?
Description

MRI

Data type

boolean

Alias
UMLS CUI [1]
C0024485
Date of MRI
Description

MRI Date

Data type

date

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C0011008
Amount of T2 lesions
Description

MRI T2 Lesion

Data type

integer

Alias
UMLS CUI [1,1]
C0412676
UMLS CUI [1,2]
C0221198
UMLS CUI [1,3]
C0026769
T1 lesions?
Description

MRI T1 Lesions

Data type

boolean

Alias
UMLS CUI [1,1]
C2029669
UMLS CUI [1,2]
C0221198
UMLS CUI [1,3]
C0026769
Gadolinium-enhancing lesions?
Description

Gd-Enhancing Lesions

Data type

boolean

Alias
UMLS CUI [1]
C1333400

Similar models

Inflammatory demyelinating diseases CNS Core Data Set

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Diagnosis Demyelinating disease of central nervous system
C0011900 (UMLS CUI-1)
C0011302 (UMLS CUI-2)
Item
Current Diagnosis
text
C0011900 (UMLS CUI [1])
Code List
Current Diagnosis
CL Item
Radiologically Isolated Syndrome (RIS) (1)
CL Item
Clinically Isolated Syndrome (CIS) (2)
CL Item
Multiple Sclerosis (MS)  (3)
CL Item
Neuromyelitis Optica (NMO) (spectrum disorder)  (4)
CL Item
Acute Disseminated Encephalomyelitis (ADEM) (5)
CL Item
Other CNS demyelinating disorder (6)
Other CNS demyelinating disorder
Item
Other CNS demyelinating disorder
text
C0449259 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Date of Onset
Item
Date of onset
date
C0574845 (UMLS CUI [1])
Date of Diagnosis
Item
Date of diagnosis
date
C2316983 (UMLS CUI [1])
Item Group
Current Flare
Current flare
Item
Current flare?
boolean
C1517205 (UMLS CUI [1,1])
C0521116 (UMLS CUI [1,2])
Item
Current Therapy Flare
text
C1517205 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
Code List
Current Therapy Flare
CL Item
Methylprednisolone (25)
CL Item
Plasmaseparation (1)
CL Item
other (2)
Other Therapy Flare
Item
Other therapy for current flare
text
C0205394 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C1517205 (UMLS CUI [1,3])
Start Date Current Flare Therapy
Item
Start date of current flare therapy
date
C3173309 (UMLS CUI [1])
End Date Current Flare Therapy
Item
End date of current flare therapy
date
C1531784 (UMLS CUI [1])
Item Group
Multiple Sclerosis
C0026769 (UMLS CUI-1)
Item
Clinical course of multiple sclerosis
integer
C0449259 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
Code List
Clinical course of multiple sclerosis
CL Item
Relapsing-remitting MS (RRMS) (2)
CL Item
Secondary progressive MS (SPMS) (3)
CL Item
Primary progressive MS (PPMS) (4)
CL Item
Others (5)
CL Item
uncertain (-1)
Other clinical course MS
Item
Other clinical course
text
C0449259 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Neuromyelitis optica
C0027873 (UMLS CUI-1)
Item
Clinical course of NMO Spectrum Disorder
text
C0449259 (UMLS CUI [1,1])
C0027873 (UMLS CUI [1,2])
Code List
Clinical course of NMO Spectrum Disorder
CL Item
Monophasic  (1)
CL Item
Relapsing  (2)
CL Item
Recurrent optic neuritis  (3)
CL Item
Recurrent myelitis  (4)
CL Item
Unknown  (5)
CL Item
Other (6)
Other clinical course NMO
Item
Other clinical course
text
C0449259 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item
Aquaporin-4 antibody
text
C2919772 (UMLS CUI [1])
Code List
Aquaporin-4 antibody
CL Item
seropositive (seropositive)
CL Item
seronegative (seronegative)
CL Item
not determined (not determined)
Item
anti-MOG (Myelin oligodendrocyte glycoprotein) antibodies
text
C0003241 (UMLS CUI [1,1])
C3266851 (UMLS CUI [1,2])
Code List
anti-MOG (Myelin oligodendrocyte glycoprotein) antibodies
CL Item
seropositive (seropositive)
CL Item
seronegative (seronegative)
CL Item
not determined (not determined)
Item Group
Acute Disseminated Encephalomyelitis (ADEM)
C0014059 (UMLS CUI-1)
Item
Clinical course of ADEM
text
C0449259 (UMLS CUI [1,1])
C0014059 (UMLS CUI [1,2])
Code List
Clinical course of ADEM
CL Item
Monophasic  (1)
CL Item
Recurrent  (2)
CL Item
Unknown  (4)
CL Item
Other (5)
Other clinical course ADEM
Item
Other clinical course
text
C0449259 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
EDSS
Item
Today's EDSS
text
C3830336 (UMLS CUI [1])
Code List
Today's EDSS
CL Item
Normal neurologic exam (all grade 0 in Functional Systems [FS]; Cerebral grade 1 acceptable) (0 )
CL Item
No disability, minimal signs in one FS (ie, grade 1 excluding Cerebral grade 1) (1.0 )
CL Item
No disability minimal signs in more than one FS (more than one grade 1 excluding Cerebral grade 1) (1.5 )
CL Item
Minimal disability in one FS (one FS grade 2, others 0 or 1) (2.0 )
CL Item
Minimal disability in two FS (two FS grade 2, others 0 or 1) (2.5 )
CL Item
Moderate disability in one FS (one FS grade 3, others 0 or l), or mild disability in three or four FS (three/four FS grade 2, others 0 or 1) though fully ambulatory (3.0 )
CL Item
Fully ambulatory but with moderate disability in one FS (one grade 3) and one or two FS grade 2; or two FS grade 3; or five FS grade 2 (others 0 or 1) (3.5 )
CL Item
Fully ambulatory without aid, self-sufficient, up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or l), or combinations of lesser grades exceeding limits of previous steps. Able to walk without aid or rest some 500 meters. (4.0 )
CL Item
Fully ambulatory without aid, up and about much of the day, able to work a full day, may otherwise have some limitation of full activity or require minimal assistance; characterized by relatively severe disability, usually consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Able to walk without aid or rest for some 300 meters. (4.5 )
CL Item
Ambulatory without aid or rest for about 200 meters; disability severe enough to impair full daily activities (eg, to work full day without special provisions). (Usual FS equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually exceeding specifications for step 4.0.) (5.0 )
CL Item
Ambulatory without aid or rest for about 100 meters; disability severe enough to preclude full daily activities. (Usual FS equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually exceeding those for step 4.0.) (5.5 )
CL Item
Intermittent or unilateral constant assistance (cane, crutch, or brace) required to walk about 100 meters with or without resting. (Usual FS equivalents are combinations with more than two FS grade 3+.) (6.0 )
CL Item
Constant bilateral assistance (canes, crutches, or braces) required to walk about 20 meters without resting. (Usual FS equivalents are combinations with more than two FS grade 3+.) (6.5 )
CL Item
Unable to walk beyond about 5 meters even with aid, essentially restricted to wheelchair; wheels self in standard wheelchair and transfers alone; up and about in w/c some 12 hours a day. (Usual FS equivalents are combinations with more than one FS grade 4+; very rarely, pyramidal grade 5 alone.) (7.0 )
CL Item
Unable to take more than a few steps; restricted to wheelchair; may need aid in transfer; wheels self but cannot carry on in standard wheelchair a full day; may require motorized wheelchair. (Usual FS equivalents are combinations with more than one FS grade 4+.) (7.5 )
CL Item
Essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed itself much of the day; retains many self-care functions; generally has effective use of arms. (Usual FS equivalents are combinations, generally grade 4+ in several systems.) (8.0 )
CL Item
Essentially restricted to bed much of the day; has some effective use of arm(s); retains some self-care functions. (Usual FS equivalents are combinations, generally 4+ in several systems.) (8.5 )
CL Item
Helpless bed patient; can communicate and eat. (Usual FS equivalents are combinations, mostly grade 4+.) (9.0 )
CL Item
Totally helpless bed patient; unable to communicate effectively or eat/swallow. (Usual FS equivalents are combinations, almost all grade 4+.) (9.5 )
CL Item
Death due to MS (10 )
Item
KFSS Pyramidal Functions
text
C3829393 (UMLS CUI [1])
Code List
KFSS Pyramidal Functions
CL Item
Normal (0 )
CL Item
Abnormal signs without disability (1 )
CL Item
Minimal disability (2 )
CL Item
Mild or moderate paraparesis or hemiparesis; severe monoparesis (3 )
CL Item
Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia (4 )
CL Item
Paraplegia, hemiplegia, or marked quadriparesis (5 )
CL Item
Quadriplegia (6 )
CL Item
Unknown (V )
Item
KFSS Sensory Functions
text
C3829391 (UMLS CUI [1])
Code List
KFSS Sensory Functions
CL Item
Normal (0 )
CL Item
Vibration or figure-writing decrease only, in one or two limbs (1 )
CL Item
Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs (2 )
CL Item
Moderate decrease in touch or pain or position sense, and/or essentially lost vibration in one or two limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in three or four limbs (3 )
CL Item
Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs (4 )
CL Item
Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head (5 )
CL Item
Sensation essentially lost below the head (6 )
CL Item
Unknown (V )
Item
KFSS Cerebral
text
C3829397 (UMLS CUI [1])
Code List
KFSS Cerebral
CL Item
Normal (0 )
CL Item
Mood alteration only (Does not affect DSS score) (1 )
CL Item
Mild decrease in mentation (2 )
CL Item
Moderate decrease in mentation (3 )
CL Item
Marked decrease in mentation (chronic brain syndrome-moderate) (4 )
CL Item
Dementia or chronic brain syndrome-severe or incompetent (5 )
CL Item
Unknown (V )
Item
KFSS Cerebellar Functions
text
C3829398 (UMLS CUI [1])
Code List
KFSS Cerebellar Functions
CL Item
Normal (0 )
CL Item
Abnormal signs without disability (1 )
CL Item
Mild ataxia (2 )
CL Item
Moderate truncal or limb ataxia (3 )
CL Item
Severe ataxia, all limbs (4 )
CL Item
Unable to perform coordinated movements due to ataxia (5 )
CL Item
Unknown (V )
CL Item
Is used throughout after each number when weakness (grade 3 or more on pyramidal) interferes with testing (X )
Item
KFSS Bowel and Bladder Functions
text
C3829400 (UMLS CUI [1])
Code List
KFSS Bowel and Bladder Functions
CL Item
Normal (0 )
CL Item
Mild urinary hesitancy, urgency, or retention (1 )
CL Item
Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence (2 )
CL Item
Frequent urinary incontinence (3 )
CL Item
In need of almost constant catheterization (4 )
CL Item
Loss of bladder function (5 )
CL Item
Loss of bowel and bladder function (6 )
CL Item
Unknown (V )
Item
KFSS Brain Stem Functions
text
C3829399 (UMLS CUI [1])
Code List
KFSS Brain Stem Functions
CL Item
Normal (0 )
CL Item
Signs only (1 )
CL Item
Moderate nystagmus or other mild disability (2 )
CL Item
Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves (3 )
CL Item
Marked dysarthria or other marked disability (4 )
CL Item
Inability to swallow or speak (5 )
CL Item
Unknown (V )
Item
KFSS Visual (or Optic) Functions
text
C3827261 (UMLS CUI [1])
Code List
KFSS Visual (or Optic) Functions
CL Item
Normal (0 )
CL Item
Scotoma with visual acuity (corrected) better than 20/30 (1 )
CL Item
Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59 (2 )
CL Item
Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99 (3 )
CL Item
Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less (4 )
CL Item
Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less (5 )
CL Item
Grade 5 plus maximal visual acuity of better eye of 20/60 or less (6 )
CL Item
Unknown (V )
CL Item
Is added to grades 0 to 6 for presence of temporal pallor (X )
Item
FSS Ambulation Score
text
C115790 (UMLS CUI [1])
Code List
FSS Ambulation Score
CL Item
Asymptomatic; fully active.  (0 )
CL Item
Walks normally, but reports fatigue that interferes with athletic or other demanding activities.  (1 )
CL Item
Abnormal gait or episodic imbalance; gait disorder is noticed by family and friends; able to walk 25 feet (8 meters) in 10 seconds or less.  (2 )
CL Item
Walks independently; able to walk 25 feet in 20 seconds or less.  (3 )
CL Item
Requires unilateral support (cane or single crutch) to walk; walks 25 feet in 20 seconds or less.  (4 )
CL Item
Requires bilateral support (canes, crutches, or walker) and walks 25 feet in 20 seconds or less; or requires unilateral support but needs more than 20 seconds to walk 25 feet.  (5 )
CL Item
Requires bilateral support and more than 20 seconds to walk 25 feet; may use wheelchair on occasion.  (6 )
CL Item
Walking limited to several steps with bilateral support; unable to walk 25 feet; may use wheelchair* for most activities. (7 )
CL Item
Restricted to wheelchair; able to transfer self independently.  (8 )
CL Item
Restricted to wheelchair; unable to transfer self independently. (9 )
Item Group
Current MS therapy
Item
Active ingredient in current therapy
text
C2827774 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
Code List
Active ingredient in current therapy
CL Item
Glatirameracetat (Copaxone) (6)
C0289884 (UMLS CUI-1)
CL Item
Interferon-ß 1a i.m. (Avonex) (19)
C0254119 (UMLS CUI-1)
C0021492 (UMLS CUI-2)
CL Item
Interferon-ß 1a s.c. (Rebif 22 µg, Rebif 44 µg) (20)
C0254119 (UMLS CUI-1)
CL Item
Interferon-ß 1b s.c. (Betaferon, Extavia) (21)
C0244713 (UMLS CUI-1)
CL Item
Fumarate (BG-12; Tecfidera) (24)
C0058218 (UMLS CUI-1)
CL Item
Teriflunomide (Aubagio) (23)
C1718383 (UMLS CUI-1)
CL Item
Azathioprine (2)
C0004482 (UMLS CUI-1)
CL Item
Intravenous immune globulins (IVIg) (7)
C0021027 (UMLS CUI-1)
CL Item
Alemtuzumab (Lemtrada) (22)
C0383429 (UMLS CUI-1)
CL Item
Fingolimod (Gilenya) (18)
C1699926 (UMLS CUI-1)
CL Item
Natalizumab (Tysabri) (11)
C1172734 (UMLS CUI-1)
CL Item
Mitoxantrone (10)
C0026259 (UMLS CUI-1)
CL Item
Cyclophosphamide (4)
C0010583 (UMLS CUI-1)
CL Item
Methotrexate (9)
C0025677 (UMLS CUI-1)
CL Item
Rituximab (14)
C0393022 (UMLS CUI-1)
CL Item
PEG-Interferon-ß 1a s.c. (3)
CL Item
* Medication from a MS study (8)
C0013175 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
CL Item
Others... (99)
C1115771 (UMLS CUI-1)
Other Current Agent
Item
Other active ingredient in current therapy
text
C2827774 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Start Date Current Therapy
Item
Start date of current therapy
date
C3173309 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Item Group
Previous disease-modifying MS-Medication
Previous Therapy MS
Item
Was a disease-modifying MS therapy previously conducted?
boolean
C2114510 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
Item
Active ingredient in previous therapy
integer
C2114510 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
Code List
Active ingredient in previous therapy
CL Item
Glatirameracetat (Copaxone) (6)
C0289884 (UMLS CUI-1)
CL Item
Interferon-ß 1a i.m. (Avonex) (19)
C0254119 (UMLS CUI-1)
C0021492 (UMLS CUI-2)
CL Item
Interferon-ß 1a s.c. (Rebif 22 µg, Rebif 44 µg) (20)
C0254119 (UMLS CUI-1)
CL Item
Interferon-ß 1b s.c. (Betaferon, Extavia) (21)
C0244713 (UMLS CUI-1)
CL Item
Fumarate (BG-12; Tecfidera) (24)
C0058218 (UMLS CUI-1)
CL Item
Teriflunomide (Aubagio) (23)
C1718383 (UMLS CUI-1)
CL Item
Azathioprine (2)
C0004482 (UMLS CUI-1)
CL Item
Intravenous immune globulins (IVIg) (7)
C0021027 (UMLS CUI-1)
CL Item
Alemtuzumab (Lemtrada) (22)
C0383429 (UMLS CUI-1)
CL Item
Fingolimod (Gilenya) (18)
C1699926 (UMLS CUI-1)
CL Item
Natalizumab (Tysabri) (11)
C1172734 (UMLS CUI-1)
CL Item
Mitoxantrone (10)
C0026259 (UMLS CUI-1)
CL Item
Cyclophosphamide (4)
C0010583 (UMLS CUI-1)
CL Item
Methotrexate (9)
C0025677 (UMLS CUI-1)
CL Item
Rituximab (14)
C0393022 (UMLS CUI-1)
CL Item
PEG-Interferon-ß 1a s.c. (3)
CL Item
* Medication from a MS study (8)
C0013175 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
CL Item
Others... (99)
C1115771 (UMLS CUI-1)
Other Previous Agent
Item
Other active ingredient of previous therapy
text
C2114510 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Start Date Previous Therapy
Item
Start date of previous therapy
date
C3173309 (UMLS CUI [1,1])
C2114510 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
End Date Previous Therapy
Item
End date of previous therapy
date
C1531784 (UMLS CUI [1,1])
C2114510 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Item
Main reason for stopping the previous therapy
integer
C0850893 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Code List
Main reason for stopping the previous therapy
CL Item
Side effects (1)
C0877248 (UMLS CUI-1)
CL Item
Lack effectiveness (2)
C0235828 (UMLS CUI-1)
CL Item
Another reason (99)
C0205394 (UMLS CUI-1)
Other Reason Stop Therapy
Item
If other reasion for stopping previous therapy, please indicate the reason
text
C3840932 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Item Group
MRI Multiple Sclerosis
MRI
Item
MRI available?
boolean
C0024485 (UMLS CUI [1])
MRI Date
Item
Date of MRI
date
C0024485 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Amount of T2 lesions
integer
C0412676 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Code List
Amount of T2 lesions
CL Item
0 (1)
CL Item
1-8 (2)
CL Item
≤9 (3)
MRI T1 Lesions
Item
T1 lesions?
boolean
C2029669 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Gd-Enhancing Lesions
Item
Gadolinium-enhancing lesions?
boolean
C1333400 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial